We determined that there were no statistically significant differences between both groups regarding all parameters except ANGPTL-4 levels, which were higher in the MCD group (184.55 pg/ml) in contrast to 73.46 pg/ml in the FSGS group. This evidence concerns the gene ANGPTL4 and focal segmental glomerulosclerosis.